BMJ Best Practice

参考文献

关键文献

Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018;54:177-184.

Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol. 1995;131:539-543.

参考文章

1.  Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018;54:177-184.

2.  Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012;51:889-902.

3.  French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. 2nd ed. London, UK: Mosby-Elsevier; 2008:287-300.

4.  Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92-6.

5.  Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol. 1995;131:539-543.

6.  Xia Y, Yang Z, Chen S, et al. Extranodal NK/T-cell lymphoma mimicking erythema multiforme. Indian J Dermatol. 2015;60:322.

7.  Ma JH, Smith S, Gordon LA. Acute HIV infection presenting as erythema multiforme in a 45-year-old heterosexual man. Med J Aust. 2015;202:273-275.

8.  Ghosh I, Pahwa P, Dinda AK, et al. Erythema multiforme associated with metastatic breast cancer. Indian J Dermatol. 2013;58:485-486.

9.  Auquier-Dunant A, Mockenhaupt M, Maldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019-1024.

10.  Eun LY, Go JW, Kang WH, et al. Erythema multiforme associated with Kawasaki Disease in a Korean child. Eur J Dermatol. 2010;20:524-525.

11.  Kishore BN, Ankadavar NS, Kamath GH, et al. Varicella zoster with erythema multiforme in a young girl: a rare association. Indian J Dermatol. 2014;59:299-301.

12.  Kasuya A, Sakabe J, Kageyama R, et al. Successful differentiation of herpes zoster-associated erythema multiforme from generalized extension of herpes by rapid polymerase chain reaction analysis. J Dermatol. 2014;41:542-544.

13.  Borrás-Blasco J, Navarro-Ruiz A, Borrás C, et al. Adverse cutaneous reactions induced by TNF-alpha antagonist therapy. South Med J. 2009;102:1133-1140.

14.  Lenalidomide: Stevens-Johnson syndrome. Prescrire Int. 2010;19:125.

15.  Ballester I, Guijarro J, Silvestre JF, et al. Erythema multiforme induced by imiquimod 5% cream. Int J Dermatol. 2014;53:e347-e348.

16.  Chahal D, Aleshin M, Turegano M et al. Vaccine-induced toxic epidermal necrolysis: A case and systematic review. Dermatol Online J. 2018;24: pii: 13030/qt7qn5268s.

17.  Allione A, Dutto L, Castagna E, et al. Erythema multiforme caused by tattoo: a further case. Intern Emerg Med. 2011;6:263-265.

18.  Sai Keerthana PC, Anila KN, Reshma R. Naproxen induced erythema multiforme - A rare case report. Int J Pharm and Pharmaceutical Sci. 2017;9:294-295.

19.  Rodríguez-Pazos L, Sánchez-Aguilar D, Rodríguez-Granados MT, et al. Erythema multiforme photoinduced by statins. Photodermatol Photoimmunol Photomed. 2010;26:216-218.

20.  Lamoreux MR, Stern MR, Hsu WT. Erythema multiforme. Am Fam Physician. 2006;74:1883-1888.

21.  Gantala R, Devaraju RR, G SG, et al. Condiments costing high. . . ! A case report of erythema multiforme. J Clin Diagn Res. 2015;9:ZD22-ZD24.

22.  Kumar MS, Kumar MH, Kumar VS, et al. Herpes-associated erythema multiforme worsened by a Siddha drug, Alpinia galanga, in an 18-year-old man. BMJ Case Rep. 2015;2015.pii: bcr2015212303.

23.  Sundram U. A review of important skin disorders occurring in the posttransplantation patient. Adv Anat Pathol. 2014;21:321-329.

24.  Ng PP, Sun YJ, Tan HH, et al. Detection of HSV genomic DNA in various subsets of Erythema multiforme by polymerase chain reaction. Dermatology. 2003;207:349-353.

25.  Ono F, Sharma BK, Smith CC, et al. CD34+ cells in the peripheral blood transport HSV DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol. 2005;124:1215-1224.

26.  Kokuba H, Aurelian L, Burnett J. HSV associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatol. 1999;113:808-815.

27.  Wetter DA, Davis MD. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol. 2010;62:45-53.

28.  Amode R, Ingen-Housz-Oro S, Ortonne N et al. Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme: A single-center series of 33 cases compared with 100 cases induced by other causes. J Am Acad Dermatol. 2018;79:110-117.

29.  Joseph RH, Haddad FA, Matthews AL, et al. Erythema multiforme after orf virus infection: a report of two cases and literature review. Epidemiol Infect. 2015;143:385-390.

30.  Utsunomiya A, Oyama N, Iino S et al. A case of erythema multiforme major developed after sequential use of two immune checkpoint inhibitors, nivolumab and ipilimumab, for advanced melanoma: Possible implication of synergistic and/or complementary immunomodulatory effects. Case Rep Dermatol. 2018;10:1-6.

31.  Chiang MC, Chiang FC, Chang YT, et al. Erythema multiforme caused by Treponema pallidum in a young patient with human immunodeficiency virus infection. J Clin Microbiol. 2010;48:2640-2642.

32.  Cote B, Wechsler J, Bastuji-Garin S. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol. 1995;131:1268-1272.

33.  Lee HJ, Kwon JA, Kim JW. Erythema multiforme-like molluscum dermatitis. Acta Derm Venereol. 2002;82:217-218.

34.  Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72.

35.  Oak AS, Seminario-Vidal L, Sami N. Treatment of antiviral-resistant recurrent erythema multiforme with dapsone. Dermatol Ther. 2016 Nov 18 [Epub ahead of print].

36.  Hirsch G, Ingen-Housz-Oro S, Fite C, et al. Rituximab, a new treatment for difficult-to-treat chronic erythema multiforme major? Five cases. J Eur Acad Dermatol Venereol. 2016;30:1140-1143.

37.  Baillis B, Maize JC Sr. Treatment of recurrent erythema multiforme with adalimumab as monotherapy. JAAD Case Rep. 2017;3:95-97.

38.  Davis MD, Rogers RS, Pittelkow MR. Recurrent erythema multiforme/Stevens-Johnson syndrome: response to mycophenolate mofetil. Arch Dermatol. 2002;138:1547-1550.

39.  Jones RR. Azathioprine therapy in the management of persistent erythema multiforme. Br J Dermatol. 1981;105:465-467.

40.  Bakis S, Zagarella S. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme. Australas J Dermatol. 2005;46:18-20.

41.  Morison WL, Anhalt GJ. Therapy with oral psoralen plus UV-A for erythema multiforme. Arch Dermatol. 1997;133:1465-1466.

使用此内容应接受我们的免责声明